10th May 2022
Want to access this resource?
OR LOGIN IF YOU ARE ALREADY REGISTERED
A paediatric metabolic specialist presents international data on the growing use of empagliflozin to manage neutropenia in GSD type Ib.
Dr Sarah Grünert
University Children's Hospital Freiburg, Germany
PKU - Infants
PKU - Children
PKU - Adolescents and Adults
Maternal PKU
PKU & GMP
Rare disorders of protein metabolism
Lipid Disorders
Glycogen Storage Disease
Ketogenic Diet
K.Vita
Paediatric Kidney Disease
Nutrition Support